Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noemí Reguart

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Management and Research|December 29, 2010
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancerNoemí Reguart, Andrés Felipe Cardona, Rafael Rosell
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patientsAndrés Felipe Cardona, Noemí Reguart, Ludovic Reveiz
Therapeutic Advances in Medical Oncology|April 18, 2018
PD-L1 expression testing in non-small cell lung cancerCristina Teixidó, Noelia Vilariño, Roxana Reyes, et al.
Future Oncology (London, England)|March 25, 2006
Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutationsRafael Rosell, Enriqueta Felip, Noemí Reguart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?Jordi Remon, Noemí Reguart, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2017
Successful Treatment with Gefitinib in Advanced Non-Small Cell Lung Cancer after Acquired Resistance to OsimertinibNuria Chic, Clara Mayo-de-Las-Casas, Noemí Reguart
Drugs|January 9, 2020
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung CancerNoemí Reguart, Elba Marin, Jordi Remon, et al.
Clinical Lung Cancer|December 17, 2008
BRCA1: a new genomic marker for non-small-cell lung cancerNoemí Reguart, Andrés Felipe Cardona, Esther Carrasco, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 7, 2012
Sleeve lobectomy after induction chemoradiotherapyAbel Gómez-Caro, Marc Boada, Noemí Reguart, et al.
Cancers|August 7, 2021
Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic OpportunitiesJordi Alcaraz, Rafael Ikemori, Alejandro Llorente, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Management and Research|December 29, 2010
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancerNoemí Reguart, Andrés Felipe Cardona, Rafael Rosell
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patientsAndrés Felipe Cardona, Noemí Reguart, Ludovic Reveiz
Therapeutic Advances in Medical Oncology|April 18, 2018
PD-L1 expression testing in non-small cell lung cancerCristina Teixidó, Noelia Vilariño, Roxana Reyes, et al.
Future Oncology (London, England)|March 25, 2006
Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutationsRafael Rosell, Enriqueta Felip, Noemí Reguart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?Jordi Remon, Noemí Reguart, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2017
Successful Treatment with Gefitinib in Advanced Non-Small Cell Lung Cancer after Acquired Resistance to OsimertinibNuria Chic, Clara Mayo-de-Las-Casas, Noemí Reguart
Drugs|January 9, 2020
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung CancerNoemí Reguart, Elba Marin, Jordi Remon, et al.
Clinical Lung Cancer|December 17, 2008
BRCA1: a new genomic marker for non-small-cell lung cancerNoemí Reguart, Andrés Felipe Cardona, Esther Carrasco, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 7, 2012
Sleeve lobectomy after induction chemoradiotherapyAbel Gómez-Caro, Marc Boada, Noemí Reguart, et al.
Cancers|August 7, 2021
Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic OpportunitiesJordi Alcaraz, Rafael Ikemori, Alejandro Llorente, et al.
Pageof 8